O. E. Savelieva

421 total citations
31 papers, 299 citations indexed

About

O. E. Savelieva is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, O. E. Savelieva has authored 31 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in O. E. Savelieva's work include Cancer Cells and Metastasis (17 papers), Cancer Genomics and Diagnostics (7 papers) and Metastasis and carcinoma case studies (6 papers). O. E. Savelieva is often cited by papers focused on Cancer Cells and Metastasis (17 papers), Cancer Genomics and Diagnostics (7 papers) and Metastasis and carcinoma case studies (6 papers). O. E. Savelieva collaborates with scholars based in Russia and Greece. O. E. Savelieva's co-authors include V. М. Perelmuter, Л. А. Таширева, М. V. Zavyalova, Evgeny V. Denisov, Е. В. Кайгородова, Н. В. Чердынцева, N. V. Krakhmal, С. В. Вторушин, Е. М. Slonimskaya and Е. L. Choynzonov and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

O. E. Savelieva

26 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. E. Savelieva Russia 11 192 137 119 49 43 31 299
Jana Plavá Slovakia 8 208 1.1× 137 1.0× 164 1.4× 38 0.8× 42 1.0× 16 357
Magdalena Książkiewicz Poland 7 238 1.2× 116 0.8× 143 1.2× 27 0.6× 64 1.5× 7 328
Trevor G. Levin United States 6 189 1.0× 74 0.5× 147 1.2× 21 0.4× 35 0.8× 15 314
Sanket H. Shah United States 4 185 1.0× 189 1.4× 218 1.8× 51 1.0× 58 1.3× 4 390
Mireia Berdiel‐Acer Spain 9 207 1.1× 102 0.7× 151 1.3× 15 0.3× 53 1.2× 13 313
Sebastián A. García Germany 8 231 1.2× 155 1.1× 101 0.8× 36 0.7× 60 1.4× 11 346
Kendelle J. Murphy Australia 8 204 1.1× 72 0.5× 142 1.2× 56 1.1× 69 1.6× 12 324
Marion Gilormini France 5 138 0.7× 93 0.7× 169 1.4× 25 0.5× 25 0.6× 7 329
Victoria M.-Y. Wang United Kingdom 6 141 0.7× 99 0.7× 179 1.5× 47 1.0× 27 0.6× 8 344
Shivee Gilja United States 3 207 1.1× 117 0.9× 175 1.5× 20 0.4× 37 0.9× 5 359

Countries citing papers authored by O. E. Savelieva

Since Specialization
Citations

This map shows the geographic impact of O. E. Savelieva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. E. Savelieva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. E. Savelieva more than expected).

Fields of papers citing papers by O. E. Savelieva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. E. Savelieva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. E. Savelieva. The network helps show where O. E. Savelieva may publish in the future.

Co-authorship network of co-authors of O. E. Savelieva

This figure shows the co-authorship network connecting the top 25 collaborators of O. E. Savelieva. A scholar is included among the top collaborators of O. E. Savelieva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. E. Savelieva. O. E. Savelieva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Savelieva, O. E., et al.. (2025). Cytotoxicity mechanisms of passive anti-GD2 immunotherapy in pediatric tumors. Advances in molecular oncology. 12(2). 47–57.
2.
3.
Perelmuter, V. М., O. E. Savelieva, М. V. Zavyalova, et al.. (2024). Characterization of EpCAM-Positive and EpCAM-Negative Tumor Cells in Early-Stage Breast Cancer. International Journal of Molecular Sciences. 25(20). 11109–11109. 3 indexed citations
4.
Perelmuter, V. М., O. E. Savelieva, М. V. Zavyalova, et al.. (2024). EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients. Scientific Reports. 14(1). 12245–12245. 8 indexed citations
5.
Таширева, Л. А., et al.. (2023). The Association of Integrins β3, β4, and αVβ5 on Exosomes, CTCs and Tumor Cells with Localization of Distant Metastasis in Breast Cancer Patients. International Journal of Molecular Sciences. 24(3). 2929–2929. 24 indexed citations
6.
Schwartz, D. R., et al.. (2023). Genetic Discrimination of Grade 3 and Grade 4 Gliomas by Artificial Neural Network. Cellular and Molecular Neurobiology. 44(1). 13–13. 1 indexed citations
7.
Таширева, Л. А., Tatiana S. Gerashchenko, O. E. Savelieva, et al.. (2022). Heterogeneity of Circulating Epithelial Cells in Breast Cancer at Single‐Cell Resolution: Identifying Tumor and Hybrid Cells. Advanced Biology. 7(2). e2200206–e2200206. 10 indexed citations
8.
Таширева, Л. А., O. E. Savelieva, С. В. Вторушин, et al.. (2022). Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer. Scientific Reports. 12(1). 20949–20949. 6 indexed citations
9.
Denisov, Evgeny V., Tatiana S. Gerashchenko, Л. А. Таширева, et al.. (2021). 23P Transcriptional profiling of circulating tumor and hybrid cells in breast cancer patients. Annals of Oncology. 32. S367–S368. 1 indexed citations
10.
Таширева, Л. А., O. E. Savelieva, Evgeny V. Denisov, et al.. (2021). Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients. International Journal of Molecular Sciences. 22(5). 2504–2504. 20 indexed citations
11.
Savelieva, O. E., et al.. (2020). 6P Role of inflammatory cytokines in distant metastasis of non-small cell lung cancer. Annals of Oncology. 31. S1419–S1419. 1 indexed citations
12.
Таширева, Л. А., М. V. Zavyalova, O. E. Savelieva, et al.. (2020). Single Tumor Cells With Epithelial-Like Morphology Are Associated With Breast Cancer Metastasis. Frontiers in Oncology. 10. 50–50. 8 indexed citations
13.
Zavyalova, М. V., Evgeny V. Denisov, Л. А. Таширева, et al.. (2019). Intravasation as a Key Step in Cancer Metastasis. Biochemistry (Moscow). 84(7). 762–772. 61 indexed citations
14.
Syridou, Garyfallia, et al.. (2019). Influenza a H1N1 associated acute glomerulonephritis in an adolescent. IDCases. 19. e00659–e00659. 2 indexed citations
15.
Perelmuter, V. М., Л. А. Таширева, O. E. Savelieva, et al.. (2019). <p>Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment</p>. Breast Cancer Targets and Therapy. Volume 11. 209–219. 11 indexed citations
16.
Savelieva, O. E., Л. А. Таширева, М. А. Булдаков, et al.. (2018). CXCR4 EXPRESSION IN DIFFERENT SUBSETS OF CTCs AND SINGLE (DETACHED) BREAST CANCER CELLS. Siberian Journal of Oncology. 17(4). 75–80. 1 indexed citations
17.
Таширева, Л. А., et al.. (2017). Types of immune-inflammatory responses as a reflection of cell–cell interactions under conditions of tissue regeneration and tumor growth. Biochemistry (Moscow). 82(5). 542–555. 18 indexed citations
18.
Кайгородова, Е. В., et al.. (2017). Effect of small and radical surgical injury on the level of different populations of circulating tumor cells in the blood of breast cancer patients. Neoplasma. 64(3). 437–443. 10 indexed citations
19.
Savelieva, O. E., et al.. (2017). INFLAMMATION AS A THERAPEUTIC TARGET IN THE COMPLEX TREATMENT OF MALIGNANT TUMORS. Siberian Journal of Oncology. 16(3). 65–78. 3 indexed citations
20.
Таширева, Л. А., Evgeny V. Denisov, O. E. Savelieva, et al.. (2015). A14. European Journal of Cancer Supplements. 13(1). 61–61.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jana Plavá Breakdown of academic impact, for papers by Magdalena Książkiewicz Breakdown of academic impact, for papers by Trevor G. Levin Breakdown of academic impact, for papers by Sanket H. Shah Breakdown of academic impact, for papers by Mireia Berdiel‐Acer Breakdown of academic impact, for papers by Sebastián A. García Breakdown of academic impact, for papers by Kendelle J. Murphy Breakdown of academic impact, for papers by Marion Gilormini Breakdown of academic impact, for papers by Victoria M.-Y. Wang Breakdown of academic impact, for papers by Shivee Gilja
Rankless by CCL
2026